Scientific article
Case report
OA Policy
English

Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis

Published inJournal of neurology, neurosurgery and psychiatry, vol. 77, no. 9, p. 1079-1082
Publication date2006-09
Abstract

Progressive multifocal leucoencephalopathy (PML), a demyelinating disease caused by the JC virus (JCV), occurs in immunosuppressed patients and carries a poor prognosis. A favourable outcome is reported in two patients with PML and dermatomyositis. Immunosuppressive drugs were stopped in patient 1 but could only be partially tapered in patient 2. The JCV-specific CD8+ T cell response was strong in patient 1 and weak in patient 2. Both were treated with cytosine-arabinoside, and patient 2 was also treated with mirtazapine, a 5HT2A receptor antagonist. Combination of these drugs might be helpful to treat HIV-negative patients with PML.

Keywords
  • Adrenergic alpha-Antagonists / therapeutic use
  • Cytarabine / therapeutic use
  • Dermatomyositis / complications
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Leukoencephalopathy, Progressive Multifocal / drug therapy
  • Leukoencephalopathy, Progressive Multifocal / etiology
  • Male
  • Mianserin / analogs & derivatives
  • Mianserin / therapeutic use
  • Middle Aged
  • Mirtazapine
  • Treatment Outcome
Citation (ISO format)
VULLIEMOZ, Serge et al. Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. In: Journal of neurology, neurosurgery and psychiatry, 2006, vol. 77, n° 9, p. 1079–1082. doi: 10.1136/jnnp.2006.092353
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
Journal ISSN0022-3050
188views
169downloads

Technical informations

Creation17/11/2021 16:40:00
First validation17/11/2021 16:40:00
Update16/03/2023 01:51:01
Status update16/03/2023 01:51:01
Last indexation31/10/2024 23:50:20
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack